McLean Hospital
Belmont, Massachusetts, 02478, United States
NCT Number: NCT01596231
This is a study designed to test whether a single administration of kudzu extract (2 mg) will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session when given as pretreatment 2 ½ hours before the drinking session.
Looking for future studies?
Notify Me21 year–40 year
All sexes
Interventional
Phase 2
Belmont, Massachusetts, 02478, United States
In a laboratory experimental setting, subjects will be treated with placebo or 2 grams of kudzu extract 2.5 hours before an afternoon drinking session. The investigators hypothesis is that the kudzu pretreatment will reduce alcohol consumption in this free choice, self-administration paradigm.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Kudzu (2 mg) will be administered as a pretreatment 2 ½ hours before a drinking session to see if it will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session.
Other names: Kudzu root extract (NPI-031), Puerariae lobata, Alkontrol-Herbal®
Placebo will be administered as a pretreatment 2 ½ hours before a drinking session
Time frame: Study end
A variety of measures describing the drinking behavior will be analyzed with appropriate parametric tests (t-test, analysis of variance): number of beers consumed, weight and volume consumed, sip analysis (number, interlude), and latency (time to open first and subsequent drinks).
Mclean Hospital
Other
Isoflavone (Kudzu) Extract Effects on Alcohol Drinking: Single Dose Pretreatment Study
Acronym: KUDZU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04360018
Alcohol Consumption, Alcohol Drinking
Bethesda, Maryland, United States
View Trial DetailsNCT06624514
Alcohol Consumption, Alcohol Drinking
Charleston, South Carolina, United States
View Trial DetailsNCT04095065
Alcohol Consumption, Alcohol Drinking
Fresno, California, United States
View Trial DetailsNCT04625465
Aberrant Motor Behavior in Dementia, Aggression
Atlanta, Georgia, United States
View Trial Details